Arthritis Health Center

This article is from the WebMD News Archive

Font Size
A
A
A

Study: No Long-Lasting Vioxx Heart Risk

Risk Goes Away When Vioxx Use Stops; Low-Dose Celebrex Seems Safe
By Daniel J. DeNoon
WebMD Health News

Jan. 31, 2005 -- The heart attack risk linked to Vioxx goes away after a person stops taking the drug, data from elderly Canadians shows.

"It wasn't enough you took Vioxx three months ago -- you actually had to be currently exposed to have an increased risk of heart attack," James M. Brophy, MD, PhD, tells WebMD. "How long after you take Vioxx would you be considered at risk? More studies are needed to tease that out."

Brophy and colleagues at McGill University in Montreal reviewed medical records on nearly 114,000 people over the age of 66. They used the data to look at who did and who did not have a heart attack after beginning NSAID treatment.

NSAIDs (nonsteroidal anti-inflammatory drug) include traditional anti-inflammatory drugs, such as ibuprofen and naproxen, as well as newer ones, such as Celebrex and Vioxx. The new drugs -- known as Cox-2 inhibitors -- got their name because they selectively block an enzyme called Cox-2.

Brophy's team has more good news. Celebrex -- at low doses -- does not appear to increase heart attack risk.

"Yes, our study suggests that low-dose Celebrex is safe," Brophy says. "This is not a randomized study, so it is not proof of safety. But within the limits of an observational study, our data provides an element of confidence that Celebrex -- at least in conventional low dose of 200 milligrams per day -- appears to be very safe."

On the other hand, the study confirms that Vioxx -- even at a low dose -- actually does increase a person's risk of heart attack.

"Our data would tend to support the wisdom of taking Vioxx off the market," Brophy says. "The data already was rather conclusive from clinical trials. We add an element of precision, in that we have looked at a much larger population. ... In our study, 239 patients were taking Vioxx at the time of their heart attack. So we add a sense of confirmation and precision to this."

The findings come from elderly people who'd never had a heart attack before taking an NSAID.

How Safe Is High-Dose Celebrex?

Merck pulled Vioxx off pharmacy shelves when it became clear that the drug raised the risk of heart attacks. Fearing that other Cox-2 drugs might have similar -- if less dramatic -- side effects, doctors have been much more careful in prescribing Celebrex and Bextra. Some groups have called for a ban on these drugs until their heart safety can be assured.

Now, in an early release from the April 5, 2005 issue of Annals of Internal Medicine, Brophy's team provides more information. They found that:

 

  • Celebrex did not increase heart attack risk.
  • Vioxx did indeed increase heart attack risk.
  • Taking low-dose Vioxx -- 25 milligrams per day or less -- raised heart attack risk by 24%.
  • Taking high-dose Vioxx -- more than 25 milligrams per day -- increased heart attack risk by 73%.
  • People who took Vioxx in the past, but who stopped taking the drug, did not have a higher risk of heart attack.
  • Taking aspirin along with low-dose Vioxx protected against increased risk of heart attack, but taking aspirin along with high-dose Vioxx offered no protection at all.
  • Traditional NSAIDs did not increase heart attack risk. A report in December 2004 linked Aleve (naproxen) to an increase in heart attacks and strokes, but this study found no connection.

arthritis newsletter

Health information tailored to the needs of those living with arthritis. Sign up today to receive WebMD's popular Arthritis newsletter.

webMD Video

Show or hide information about video: Living with Osteoarthritis   Living with Osteoarthritis

48x48_living_with_osteoarthritis.jpg

Living with osteoarthritis? Find out how you can take steps to relieve your pain.

Watch Video: Living with Osteoarthritis (opens in a new window)

Show or hide information about video: Juvenile Arthritis   Juvenile Arthritis

Show or hide information about video: Stiff Big Toe   Stiff Big Toe

Show or hide information about video: That Aching Back   That Aching Back

Show or hide information about video: Clues of Lyme Disease Infection   Clues of Lyme Disease Infection

Advertise on Fox News Channel, FOXNews.com and FOX News Radio Jobs at FOX News Channel. Internships at FOX News Channel (now accepting Fall interns).
Terms of use. Privacy Statement. For FOXNews.com comments write to foxnewsonline@foxnews.com; For FOX News Channel comments write to comments@foxnews.com
© Associated Press. All rights reserved.
SMARTMONEY ® © 2006 SmartMoney. SmartMoney is a joint publishing venture of Dow Jones & Company, Inc. and Hearst SM Partnership. All Rights Reserved.
All quotes delayed by 20 minutes. Delayed quotes provided by ComStock.
Historical prices and fundamental data provided by Hemscott, Inc.
Mutual fund data provided by Lipper. Mutual Fund NAVs are as of previous day's close.
Earnings estimates provided by Zacks Investment Research.
Upgrades and downgrades provided by Briefing.com.
This material may not be published, broadcast, rewritten, or redistributed. © 2006 FOX News Network, LLC. All rights reserved. All market data delayed 20 minutes.